Sero-epidemiological Study in Prediction of the Risk Groups for Measles Outbreaks in Vojvodina, Serbia

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 May 10

PMID 31071124

Citations 6

Authors

Mioljub Ristic

Vesna Milosevic

Snezana Medic

Jelena Djekic Malbasa

Smiljana Rajcevic

Jasmina Boban

Vladimir Petrovic

Affiliations

Soon will be listed here.

Abstract

Background: Age-stratified serologic surveys provide insight into the gaps of measles-specific immunity as well as estimates of the age-specific seroprevalence. The aim of this study was to describe the measles sero-epidemiology in Vojvodina before the occurrence of outbreak in 2017/18 and to discuss preventive measures for potential future epidemics.

Methods: A seroprevalence study was conducted from April 2015 to June 2017 on serum bank of 3199 residual samples. Study was performed prior to the last measles outbreak in Vojvodina that occurred between 12th November 2017 and 30th June 2018. Measles-specific IgG antibodies were determined using an indirect chemiluminescent immunoassay (CLIA).

Results: Median age of enrolled participants was 20 years (IQR 11-37). Overall, 86.9% serum samples were seropositive. The highest proportion of measles seronegativity was observed in children aged 12-23 months of age and in adults aged 20-39 years (56.1% and 18.5%, respectively). Prevalence of measles seronegativity above WHO target levels susceptibility was observed in the following age groups: 2, 7, 13, 15, and among all adults aged between 20 and 49 years. Out of total measles outbreak cases (177), there were 91 (51.4%) participants aged 20-39 years. A significant positive correlation was observed between measles seronegativity and the number of reported measles cases aged ≥ 12 months (r = 0.4675, p = 0.0213).

Conclusions: In order to prevent new outbreaks and achieve the elimination of measles in Vojvodina, the vaccination coverage of both measles-mumps-rubella (MMR1 and MMR2) vaccines needs to be improved and sustained. Educational campaigns for the improvement of acceptance and timely vaccination with vaccine against measles among doctors and the general population are crucial. Our results indicate possible gap in measles protection in adults born during implementation of one dose of measles vaccine and prioritize supplementary immunization activities targeting adults in Vojvodina, Serbia.

Citing Articles

Measles Immunity Status of Greek Population after the Outbreak in 2017-2018: Results from a Seroprevalence National Survey.

Nasika A, Bogogiannidou Z, Mouchtouri V, Dadouli K, Kyritsi M, Vontas A Vaccines (Basel). 2023; 11(7).

PMID: 37515036 PMC: 10385097. DOI: 10.3390/vaccines11071220.

Effectiveness of Mandatory and Incentive-Based Routine Childhood Immunization Programs in Europe: A Systematic Review of the Literature.

Kuznetsova L, Cortassa G, Trilla A Vaccines (Basel). 2021; 9(10).

PMID: 34696280 PMC: 8538772. DOI: 10.3390/vaccines9101173.

Measles outbreak, Montenegro January-July 2018: Lessons learned.

Mugosa B, Ceccarelli G, Begic S, Vujosevic D, Zekovic Z, Ciccozzi M J Med Virol. 2021; 94(2):514-520.

PMID: 34617629 PMC: 9291602. DOI: 10.1002/jmv.27377.

Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1).

Friedrich N, Poethko-Muller C, Kuhnert R, Matysiak-Klose D, Koch J, Wichmann O Lancet Reg Health Eur. 2021; 7:100128.

PMID: 34557838 PMC: 8454806. DOI: 10.1016/j.lanepe.2021.100128.

Seroprevalence of IgG antibodies against measles in a selected Polish population - do we need to be re-vaccinated?.

Holka J, Pawlak K, Ciepiela O Cent Eur J Immunol. 2020; 44(4):380-383.

PMID: 32140049 PMC: 7050052. DOI: 10.5114/ceji.2019.92789.

References

Stanescu A, Janta D, Lupulescu E, Necula G, Lazar M, Molnar G . Ongoing measles outbreak in Romania, 2011. Euro Surveill. 2011; 16(31). View

Goodson J, Masresha B, Wannemuehler K, Uzicanin A, Cochi S . Changing epidemiology of measles in Africa. J Infect Dis. 2011; 204 Suppl 1:S205-14. DOI: 10.1093/infdis/jir129. View

Poethko-Muller C, Mankertz A . Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS). Vaccine. 2011; 29(45):7949-59. DOI: 10.1016/j.vaccine.2011.08.081. View

Wang F, Sun X, Wang F, Jiang L, Xu E, Guo J . An outbreak of adult measles by nosocomial transmission in a high vaccination coverage community. Int J Infect Dis. 2014; 26:67-70. DOI: 10.1016/j.ijid.2014.05.006. View

Dabbagh A, Patel M, Dumolard L, Gacic-Dobo M, Mulders M, Okwo-Bele J . Progress Toward Regional Measles Elimination - Worldwide, 2000-2016. MMWR Morb Mortal Wkly Rep. 2017; 66(42):1148-1153. PMC: 5689104. DOI: 10.15585/mmwr.mm6642a6. View

Nedeljkovic J, Rakic Adrovic S, Tasic G, Kovacevic-Jovanovic V, Loncarevic G, Hubschen J . Resurgence of measles in Serbia 2010-2011 highlights the need for supplementary immunization activities. Epidemiol Infect. 2015; 144(5):1121-8. DOI: 10.1017/S0950268815002277. View

Yoshikura H . Negative impacts of large population size and high population density on the progress of measles elimination. Jpn J Infect Dis. 2012; 65(5):450-4. DOI: 10.7883/yoken.65.450. View

Andrews N, Tischer A, Siedler A, Pebody R, Barbara C, Cotter S . Towards elimination: measles susceptibility in Australia and 17 European countries. Bull World Health Organ. 2008; 86(3):197-204. PMC: 2647410. DOI: 10.2471/blt.07.041129. View

Medic S, Petrovic V, Milosevic V, Lozanov-Crvenkovic Z, Brkic S, Andrews N . Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia. Epidemiol Infect. 2018; 146(12):1593-1601. PMC: 9507937. DOI: 10.1017/S0950268818001619. View

10.

Gans H, Yasukawa L, Sung P, Sullivan B, DeHovitz R, Audet S . Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age. J Infect Dis. 2013; 207(4):574-82. PMC: 3549597. DOI: 10.1093/infdis/jis719. View

11.

Dai B, Chen Z, Liu Q, Wu T, Guo C, Wang X . Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ. 1991; 69(4):415-23. PMC: 2393239. View

12.

Choi W, Sniadack D, Jee Y, Go U, So J, Cho H . Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission. J Infect Dis. 2011; 204 Suppl 1:S483-90. DOI: 10.1093/infdis/jir087. View

13.

Xiong Y, Wang D, Lin W, Tang H, Chen S, Ni J . Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China. Hum Vaccin Immunother. 2014; 10(4):1097-03. PMC: 4896514. DOI: 10.4161/hv.27734. View

14.

. Measles vaccines: WHO position paper – April 2017. Wkly Epidemiol Rec. 2017; 92(17):205-27. View

15.

Medic S, Katsilieris M, Lozanov-Crvenkovic Z, Siettos C, Petrovic V, Milosevic V . Varicella zoster virus transmission dynamics in Vojvodina, Serbia. PLoS One. 2018; 13(3):e0193838. PMC: 5837184. DOI: 10.1371/journal.pone.0193838. View

16.

Seguliev Z, duric P, Petrovic V, Stefanovic S, Cosic G, Hrnjakovic I . Current measles outbreak in Serbia: a preliminary report. Euro Surveill. 2007; 12(3):E070315.2. DOI: 10.2807/esw.12.11.03155-en. View

17.

Borcic B, Mazuran R, Kaic B . Immunity to measles in the Croatian population. Eur J Epidemiol. 2003; 18(11):1079-83. DOI: 10.1023/a:1026109201399. View

18.

Li J, Lu L, Pang X, Sun M, Ma R, Liu D . A 60-year review on the changing epidemiology of measles in capital Beijing, China, 1951-2011. BMC Public Health. 2013; 13:986. PMC: 4016557. DOI: 10.1186/1471-2458-13-986. View

19.

Grammens T, Schirvel C, Leenen S, Shodu N, Hutse V, Mendes da Costa E . Ongoing measles outbreak in Wallonia, Belgium, December 2016 to March 2017: characteristics and challenges. Euro Surveill. 2017; 22(17). PMC: 5434888. DOI: 10.2807/1560-7917.ES.2017.22.17.30524. View

20.

Kang H, Han Y, Kim S, Kim Y, Kim A, Kim J . An increasing, potentially measles-susceptible population over time after vaccination in Korea. Vaccine. 2017; 35(33):4126-4132. DOI: 10.1016/j.vaccine.2017.06.058. View